Histogen, Inc.
🏢 View company profile →12Patents
12Active
12Granted
47Portfolio score
Filing activity: Jan 30, 2009 → Mar 6, 2020 · 5 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8530415B2 | Repair and/or regeneration of cells with a composition produced by culturing fibroblast cells under hypoxic conditions | Chemistry; Metallurgy | 16 | Active |
| US8535913B2 | Soluble composition for promoting hair growth produced by hypoxic culture of fibroblasts cells | Chemistry; Metallurgy | 11 | Active |
| US8524494B2 | Low oxygen tension and BFGF generates a multipotent stem cell from a fibroblast in vitro | Chemistry; Metallurgy | 7 | Active |
| US9034312B2 | Extracellular matrix compositions for the treatment of cancer | Chemistry; Metallurgy | 6 | Active |
| US8852637B2 | Extracellular matrix compositions for the treatment of cancer | Chemistry; Metallurgy | 6 | Active |
| US11597703B2 | Caspase inhibitors and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11274276B2 | Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions | Chemistry; Metallurgy | 0 | Active |
| US10538736B2 | Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions | Chemistry; Metallurgy | 0 | Active |
| US10143708B2 | Extracellular matrix compositions for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US9506038B2 | Extracellular matrix compositions for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US9512403B2 | Conditioned medium and extracellular matrix compositions from cells cultured under hypoxic conditions for methods of treating tissue injury | Chemistry; Metallurgy | 0 | Active |
| US11447497B2 | (S)-3-(2-(4-(benzyl)-3-oxopiperazin-1-yl)acetamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid derivatives and related compounds as caspase inhibitors for treating cardiovascular diseases | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.